Medtronic plc MDT recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses ...
The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...
The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...
Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the biggest ...
Two years after submitting the latest version of its insulin pump technology for FDA approval—and three years after it was first made available in Europe—Medtronic has finally secured the agency’s ...
Credit: Getty Images. The first shipments of the MiniMed 780G system are expected this summer with preorders beginning on May 15, 2023. The Food and Drug Administration (FDA) has approved the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback